A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study to Determine the Effect of Intradermal AZD3161 on Quantitative Sensory Testing Variables in Normal and UVC Exposed Skin in Healthy Volunteers

Trial Profile

A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study to Determine the Effect of Intradermal AZD3161 on Quantitative Sensory Testing Variables in Normal and UVC Exposed Skin in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Apr 2011

At a glance

  • Drugs AZD 3161; Lidocaine
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Apr 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 11 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Feb 2011 Additional location [England] identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top